Latest & greatest articles for osteoarthritis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on osteoarthritis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on osteoarthritis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for osteoarthritis

421. Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in The Netherlands Full Text available with Trip Pro

Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in The Netherlands Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in The Netherlands Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in The Netherlands Al MJ, Maniadakis N, Grijseels EW, Janssen M Record Status This is a critical abstract of an economic evaluation (...) that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The aim was to compare the costs and upper gastrointestinal side effects of six treatments for patients with rheumatoid arthritis and osteoarthritis. Arthrotec was the most cost-effective strategy for all and for medium-to-high risk patients, while celecoxib

2008 NHS Economic Evaluation Database.

422. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

-inflammatory drugs (NSAIDs) (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis (OA) and rheumatoid arthritis (RA). Authors' conclusions The COX-2 selective NSAIDs examined were found to be similar to non-selective NSAIDs for the symptomatic relief of RA and OA and to provide superior GI tolerability (the majority of evidence is in patients with OA). Although COX-2 selective NSAIDs offer protection against serious GI events, the amount of evidence (...) Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation Cyclooxygenase-2

2008 Health Technology Assessment (HTA) Database.

423. The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate

The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

424. Effectiveness of medial-wedge insole treatment for valgus knee osteoarthritis (Abstract)

Effectiveness of medial-wedge insole treatment for valgus knee osteoarthritis To assess the efficacy of medial-wedge insoles in valgus knee osteoarthritis (OA).Thirty consecutive women with valgus-deformity knee OA > or = 8 degrees were randomized into 2 groups: medial insole (insoles with 8-mm medial elevation at the rearfoot [n = 16]) and neutral insole (similar insole without elevation [n = 14]). Both groups also wore ankle supports. A blinded examiner assessed pain on movement, at rest (...) , and at night with a visual analog scale (VAS), the Lequesne index, and Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index. Femorotibial, talocalcaneal, and talar tilt angles were evaluated at baseline and after 8 weeks of insole use.Significant reductions in the medial insole group were observed for pain on movement (mean +/- SD VAS pre- and postintervention 8.1 +/- 1.5 versus 4.2 +/- 2.4; P = 0.001), at rest (5.1 +/- 2.3 versus 2.7 +/- 2.4; P = 0.002), and at night (6.1 +/- 2.7 versus

2008 EvidenceUpdates Controlled trial quality: uncertain

425. Osteoarthritis of the knees.

Osteoarthritis of the knees. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures Funding for the National Guideline Clearinghouse (NGC) has ended

2008 Singapore Ministry of Health

426. The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: A randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period. (Abstract)

The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: A randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period. OBJECTIVE: To determine whether the efficacy of diacerein persists at 2 months after the end of a 3-month treatment period, compared with placebo, in patients with painful knee osteoarthritis (OA). METHODS: After a 1-week nonsteroidal antiinflammatory (...) drug washout period, patients received either diacerein or placebo for 3 months, followed by an off-treatment period of 3 months to determine the carryover effects of the drug. Although patients were followed up through month 6, the primary efficacy end point was the percent change from baseline in pain (Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC] A) at month 5 (i.e., 2 months after the end of treatment) compared with placebo. The co-primary efficacy end point

2008 EvidenceUpdates Controlled trial quality: predicted high

427. Glucosamine and chondroitin sulphate did not improve pain in osteoarthritis of the knee

Glucosamine and chondroitin sulphate did not improve pain in osteoarthritis of the knee Glucosamine and chondroitin sulphate did not improve pain in osteoarthritis of the knee | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Glucosamine and chondroitin sulphate did not improve pain in osteoarthritis of the knee Article Text Therapeutics Glucosamine and chondroitin sulphate did not improve pain in osteoarthritis of the knee Statistics from

2007 Evidence-Based Medicine

428. WITHDRAWN: Low level laser therapy (Classes III) for treating osteoarthritis. Full Text available with Trip Pro

in the treatment of OA.To assess the effectiveness of class III LLLT for osteoarthritis when irradiation is directed at the osteoarthritic joint capsule.Searches were conducted in the following databases: MEDLINE, EMBASE, the Cochrane Musculoskeletal registry, the Rehabilitation and Related Therapies field registry and the Cochrane Controlled Trials Register up to May, 2005.Following an a prior protocol, only controlled clinical trials of LLLT for the treatment of patients with a clinical diagnosis of OA were (...) significant difference in favor of laser treatment for patient-assessed global disease activity with laser compared to placebo (RR 1.70, 95%CI: 1.1. to 2.63). One trial evaluated the effectiveness of laser treatment in temporomandibular joint OA and found a statistically significant difference (WMD 38.69, 95% CI: 29.25 to 48.13) using the change in VAS score to measure pain. One study found a statistically significant difference in favor of laser treatment at the end of treatment and at 4 and 8 weeks post

2007 Cochrane

429. WITHDRAWN: Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. (Abstract)

WITHDRAWN: Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. Non-steroidal anti-inflammatory drugs (NSAIDs) have been widely used as a pharmacologic treatment to relieve pain for patients with OA of the hip. However, these agents are associated with significant toxicity, particularly in the elderly population (age > 65 years).To review all randomized trials of analgesics and anti-inflammatory therapy in osteoarthritis (OA) of the hip. To determine (...) which non-steroidal, anti-inflammatory drug (NSAID) is the most effective, and which NSAID is the most toxic.We searched the Cochrane Musculoskeletal Group's trials register, the Cochrane Controlled Trials Register and MEDLINE up to August 1994. Reference lists of all trials were also manually searched.All randomized controlled trials comparing non-steroidal anti-inflammatory drugs (NSAIDs) and/or analgesics in patients with Osteoarthritis. The trials selected for inclusion were identified by one

2007 Cochrane

430. WITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee. Full Text available with Trip Pro

WITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee. Osteoarthritis(OA) is the most common rheumatic disease. Simple analgesics are now accepted as the appropriate first line pharmacological treatment of uncomplicated OA. Non-aspirin NSAIDs are licensed for the relief of pain and inflammation arising from rheumatic disease.To determine whether there is a difference in the relative efficacy of individual non-steroidal anti-inflammatory drugs (...) (NSAIDs) when used in the management of osteoarthritis (OA) of the knee.We searched Medline (1966-1995) and Bids Embase (Jan-Dec, 1980-1995). The searches were limited to publications in the English language, and were last performed in November 1996. We used modified Cochrane Collaboration search strategy to identify all randomised controlled trials. The MeSH heading "osteoarthritis" was combined with the generic names of the 17 non-aspirin NSAIDs licensed in the UK for the management of OA in general

2007 Cochrane

431. Review: viscosupplementation for knee osteoarthritis reduces pain and improves function Full Text available with Trip Pro

Review: viscosupplementation for knee osteoarthritis reduces pain and improves function Review: viscosupplementation for knee osteoarthritis reduces pain and improves function | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: viscosupplementation for knee osteoarthritis reduces pain and improves function Article Text Therapeutics Review: viscosupplementation for knee osteoarthritis reduces pain and improves function Statistics from

2007 Evidence-Based Medicine

432. Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis (IPG230)

in conjunction with the clinical guideline. Description Osteoarthritis of the knee can cause pain, stiffness, swelling and difficulty in walking. An arthroscopic knee washout involves flushing the joint with fluid, which is introduced through small incisions in the knee. The procedure is often done with debridement, which is the removal of loose debris around the joint. and for this guidance. Your responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence (...) Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis (IPG230) Overview | Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis | Guidance | NICE Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis Interventional procedures guidance [IPG230] Published date: August 2007 Share Save Guidance The National Institute for Health and Clinical Excellence (NICE) has issued full guidance

2007 National Institute for Health and Clinical Excellence - Interventional Procedures

433. Acupuncture as an adjunct to exercise based physiotherapy for osteoarthritis of the knee: randomised controlled trial. Full Text available with Trip Pro

Acupuncture as an adjunct to exercise based physiotherapy for osteoarthritis of the knee: randomised controlled trial. To investigate the benefit of adding acupuncture to a course of advice and exercise delivered by physiotherapists for pain reduction in patients with osteoarthritis of the knee.Multicentre, randomised controlled trial.37 physiotherapy centres accepting primary care patients referred from general practitioners in the Midlands, United Kingdom.352 adults aged 50 or more (...) with a clinical diagnosis of knee osteoarthritis.Advice and exercise (n=116), advice and exercise plus true acupuncture (n=117), and advice and exercise plus non-penetrating acupuncture (n=119).The primary outcome was change in scores on the Western Ontario and McMaster Universities osteoarthritis index pain subscale at six months. Secondary outcomes included function, pain intensity, and unpleasantness of pain at two weeks, six weeks, six months, and 12 months.Follow-up rate at six months was 94%. The mean

2007 BMJ Controlled trial quality: predicted high

434. Topical treatments for osteoarthritis of the knee

Topical treatments for osteoarthritis of the knee Topical treatments for osteoarthritis of the knee Topical treatments for osteoarthritis of the knee Haynes S, Gemmell H CRD summary This review assessed the effectiveness of topical treatments for knee osteoarthritis and concluded that the treatments provided pain and stiffness relief and improved levels of functional disability. The authors' conclusions should be interpreted with some caution, since relevant studies may have been omitted (...) . Authors' objectives To investigate the efficacy of topically applied treatments for osteoarthritis of the knee. Searching MEDLINE, MANTIS, NCCAM (National Centre for Complementary and Alternative Medicine), AMED, CINAHL, Science Direct and The Cochrane Library were searched for studies published in English from inception to May 2005; search terms were reported. Reference lists of relevant papers were handsearched. Study selection Randomised controlled trials (RCTs) of topical treatments in patients

2007 DARE.

435. Long-term effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review

should also investigate how long the beneficial effects of exercise therapy that includes booster sessions last for, and what is required to maintain the beneficial effects of exercise therapy in the long term. Funding Not stated. Bibliographic details Pisters M F, Veenhof C, van Meeteren N L, Ostelo R W, de Bakker D H, Schellevis F G, Dekker J. Long-term effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review. Arthritis and Rheumatism (Arthritis Care (...) Long-term effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review Long-term effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review Long-term effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review Pisters M F, Veenhof C, van Meeteren N L, Ostelo R W, de Bakker D H, Schellevis F G, Dekker J CRD summary The authors concluded that positive post

2007 DARE.

436. Meta-analysis: chondroitin for osteoarthritis of the knee or hip

commentary may also be of interest. Lane N. Review: based on evidence from higher-quality trials, chondroitin does not reduce pain in knee or hip osteoarthritis. ACP J Club 2007;147:44. Indexing Status Subject indexing assigned by NLM MeSH Aged; Chondroitin Sulfates /adverse effects /therapeutic use; Female; Hip Joint /radiography; Humans; Knee Joint /radiography; Male; Middle Aged; Osteoarthritis, Hip /drug therapy /physiopathology /radiography; Osteoarthritis, Knee /drug therapy /physiopathology (...) Meta-analysis: chondroitin for osteoarthritis of the knee or hip Meta-analysis: chondroitin for osteoarthritis of the knee or hip Meta-analysis: chondroitin for osteoarthritis of the knee or hip Reichenbach S, Sterchi R, Scherer M, Trelle S, Burgi E, Burgi U, Dieppe P A, Juni P CRD summary This well-conducted and reliable review concluded that evidence from large and methodologically sound trials suggests that the symptomatic benefit of chondroitin is minimal or non-existent. However, it should

2007 DARE.

437. Effectiveness of physiotherapy exercise after knee arthroplasty for osteoarthritis: systematic review and meta-analysis of randomised controlled trials

Effectiveness of physiotherapy exercise after knee arthroplasty for osteoarthritis: systematic review and meta-analysis of randomised controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2007 DARE.

438. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis Full Text available with Trip Pro

. Research: The authors stated that intra-articular hylan should not be used in clinical research on patients with osteoarthritis of the knee. Funding Swiss National Science Foundation, grant numbers 4053-40-104762/3, 3200-066378 and 3233-066377. Bibliographic details Reichenbach S, Blank S, Rutjes A W, Shang A, King E A, Dieppe P A, Juni P, Trelle S. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis and Rheumatism (Arthritis Care and Research (...) Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis Reichenbach S, Blank S, Rutjes A W, Shang A, King E A, Dieppe P A, Juni P, Trelle S CRD summary This review found that hylan appears unlikely to be more effective than hyaluronic acid for treating pain

2007 DARE.

439. The value of individual or collective group exercise programs for knee or hip osteoarthritis: elaboration of French clinical practice guidelines

(six-minute walk test, timed get-up-and-go test, ascending and descending stairs), self-reported measures (Western Ontario and McMaster Universities Osteoarthritis Index, Arthritis Impact Measurement Scale, Activities of Daily Living) or non-steroidal anti-inflammatory drug therapy. Some studies evaluated individual and group exercises separately; others used a combination of group and individual sessions. Some of the exercise programmes were delivered in the community or in the home. The frequency (...) synthesised narratively. Results of the review Twenty-nine studies (n=4,762) were included: 21 on knee osteoarthritis; one on hip arthritis; and seven on knee and hip arthritis. Of these, 12 were of evidence level 1. The authors did not report the specific aspects of quality assessment. There was low to moderate benefit of individual exercise in improving pain (up to 36% on visual analogue scale), walking ability and muscle strength following treatment (11 studies). One year after treatment these benefits

2007 DARE.

440. Unicompartmental knee arthroplasty for the treatment of unicompartmental osteoarthritis: a systematic study Full Text available with Trip Pro

of the medial or lateral compartments of the knee were eligible for inclusion. The inclusion criteria were not specified in terms of participants but it was clear that studies of patients with unicompartmental osteoarthritis undergoing UKA, TKA and HTO were eligible. In the full systematic review, the inclusion criteria concerning participants were specified in more detail; patients with rheumatoid arthritis were not eligible (see Other Publications of Related Interest). Outcomes assessed in the review (...) for unicompartmental osteoarthritis: a systematic review. Adelaide: Royal Australian College of Surgeons, ASERNIP-S; 2005. Report No.: 44. Indexing Status Subject indexing assigned by NLM MeSH Arthroplasty, Replacement, Knee /methods; Disease Progression; Humans; Knee Prosthesis; Osteoarthritis, Knee /surgery; Osteotomy; Postoperative Complications; Range of Motion, Articular; Recovery of Function; Reoperation; Survival Analysis AccessionNumber 12007008208 Date bibliographic record published 31/03/2008 Date

2007 DARE.